Orrin Devinsky
Director/Board Member chez SILVER SPIKE III ACQUISITION CORP.
Profil
Orrin Devinsky was the founder of Regel Therapeutics Inc. (founded in 2020) and held the title of Director.
He is currently a Director at Receptor Life Sciences, Inc. (since 2018), Engage Therapeutics, Inc., Silver Spike Acquisition Corp.
II, Silver Spike III Acquisition Corp., SCRIPT Biosciences, Inc., HitchBio, Inc., and a Professor at New York University School of Medicine.
He is also a Manager at Silver Spike Capital LLC, Silver Spike Sponsor III LLC, and Managing Partner at Phifund Managers, LLC.
Mr. Devinsky has previously worked as a Director at Tevard Biosciences, Inc., and held the position of Independent Director at Silver Spike Acquisition Corp.
(from 2019 to 2021).
He has also served as a Director at SCRIPT Biosciences, Inc. Mr. Devinsky completed his graduate degree at Yale University in 1977, obtained his doctorate from Harvard Medical School in 1982, and received his undergraduate degree from Yale College in 1978.
Postes actifs de Orrin Devinsky
| Sociétés | Poste | Début |
|---|---|---|
| SILVER SPIKE ACQUISITION CORP II | Director/Board Member | - |
| SILVER SPIKE III ACQUISITION CORP. | Director/Board Member | 22/03/2021 |
Engage Therapeutics, Inc.
 Engage Therapeutics, Inc. BiotechnologyHealth Technology Engage Therapeutics, Inc. engages in the development of rescue therapy for uncontrolled epileptic seizures. The company was founded by Gregory T. Mayes III and Jouko Isojarvi in 2017 and is headquartered in Summit, NJ. | Director/Board Member | - |
Silver Spike Capital LLC
 Silver Spike Capital LLC Financial ConglomeratesFinance Silver Spike Capital LLC provides investment services. The company was founded by Scott Gordon in 2019 and is headquartered in New York. NY. | Corporate Officer/Principal | - |
Script Biosciences, Inc.
 Script Biosciences, Inc. Packaged SoftwareTechnology Services SCRIPT Biosciences, Inc. develops a genome editing platform. The American company was founded in 2020. Anil Namboodiripad has been the CEO of the company since 2021. | Director/Board Member | - |
Phifund Managers, LLC
 Phifund Managers, LLC Investment ManagersFinance Phifund Managers, LLC (Phifund Managers) is a venture capital firm founded in 2021.The firm is headquartered in New York. | Private Equity Investor | - |
Silver Spike Sponsor III LLC
 Silver Spike Sponsor III LLC Financial ConglomeratesFinance Silver Spike Sponsor III LLC provides investment services. The private company is based in New York, NY. | Corporate Officer/Principal | - |
Receptor Life Sciences, Inc.
 Receptor Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Receptor Life Sciences, Inc. operates as a pharmaceutical development company. It offer treatment of pain, central nervous systems, metabolic disorders, and gastrointestinal disorders. The company was founded in 2015 and is headquartered in Seattle, WA. | Director/Board Member | 18/03/2021 |
| New York University School of Medicine | Corporate Officer/Principal | - |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Anciens postes connus de Orrin Devinsky
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░ ░░░░░ ░░░░░░░░░░░ ░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░ | - |
| ░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Formation de Orrin Devinsky
| Yale University | Graduate Degree |
| Harvard Medical School | Doctorate Degree |
| Yale College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
Receptor Life Sciences, Inc.
Receptor Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Receptor Life Sciences, Inc. operates as a pharmaceutical development company. It offer treatment of pain, central nervous systems, metabolic disorders, and gastrointestinal disorders. The company was founded in 2015 and is headquartered in Seattle, WA. | Health Technology |
Engage Therapeutics, Inc.
Engage Therapeutics, Inc. BiotechnologyHealth Technology Engage Therapeutics, Inc. engages in the development of rescue therapy for uncontrolled epileptic seizures. The company was founded by Gregory T. Mayes III and Jouko Isojarvi in 2017 and is headquartered in Summit, NJ. | Health Technology |
Tevard Biosciences, Inc.
 Tevard Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Tevard Biosciences, Inc. is a biotechnology company based in Cambridge, MA. Tevard Biosciences is focused on developing trna-based and other modulating therapies to cure a broad range of genetic diseases. The company is advancing the use of its novel suppressor trna, enhancer trna, and mrna amplifier platforms in neurological disorders, heart disease, and muscular dystrophies. The company was founded in 2017 by Warren Burt Lammert, Harvey F. Lodish, Daniel Fischer, and Jeffrey Coller. Daniel Fischer has been the CEO since 2017. | Commercial Services |
Silver Spike Acquisition Corp.
 Silver Spike Acquisition Corp. Financial ConglomeratesFinance Silver Spike Acquisition Corp. operates as a blank check company. The firm intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded by Scott Gordon on June 7, 2019 and is headquartered in New York, NY. | Finance |
Silver Spike Capital LLC
Silver Spike Capital LLC Financial ConglomeratesFinance Silver Spike Capital LLC provides investment services. The company was founded by Scott Gordon in 2019 and is headquartered in New York. NY. | Finance |
Silver Spike Acquisition Corp. II
 Silver Spike Acquisition Corp. II Financial ConglomeratesFinance Silver Spike Acquisition Corp. II is a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on September 2, 2020 and is headquartered in New York, NY. | Finance |
Silver Spike III Acquisition Corp.
 Silver Spike III Acquisition Corp. Finance/Rental/LeasingFinance Silver Spike III Acquisition Corp. operates as a special purpose acquisition corporation. Its objective is effecting, directly or indirectly, an acquisition of one or more businesses or assets, by way of a merger, amalgamation, arrangement, share exchange, asset acquisition, share purchase, and reorganization. The company was founded on March 22, 2021 and is headquartered in New York, NY. | Finance |
Silver Spike Sponsor III LLC
Silver Spike Sponsor III LLC Financial ConglomeratesFinance Silver Spike Sponsor III LLC provides investment services. The private company is based in New York, NY. | Finance |
Regel Therapeutics Inc.
 Regel Therapeutics Inc. BiotechnologyHealth Technology Regel Therapeutics Inc. develops a proprietary technology platform related to gene therapy. The company is based in Cambridge, MA. The company was founded in 2020 by Navneet Matharu, Jordane Dimidschstein, Steven B. Ruchefsky, Michael Jasulavic, Orrin Devinsky. Steven B. Ruchefsky has been the CEO since 2020. | Health Technology |
Script Biosciences, Inc.
Script Biosciences, Inc. Packaged SoftwareTechnology Services SCRIPT Biosciences, Inc. develops a genome editing platform. The American company was founded in 2020. Anil Namboodiripad has been the CEO of the company since 2021. | Technology Services |
Phifund Managers, LLC
Phifund Managers, LLC Investment ManagersFinance Phifund Managers, LLC (Phifund Managers) is a venture capital firm founded in 2021.The firm is headquartered in New York. | Finance |
HitchBio, Inc.
 HitchBio, Inc. BiotechnologyHealth Technology HitchBio, Inc. develops solutions based on red blood cell transfusion. | Health Technology |
